questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Agents hématologiques
Coagulants
Hémostatiques
Hémostatiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Troubles de la coagulation
Tests de coagulation
Tests de coagulation
Hémostatiques
Saignement post-opératoire
Chirurgie
Antécédents médicaux
Anticoagulants
Symptômes
5
Hémorragie interne
Douleur abdominale
Troubles de la coagulation
Saignement
Réaction allergique
Hémostatiques
Prévention
5
Prévention des saignements
Interventions chirurgicales
Anticoagulants
Hygiène dentaire
Anticoagulants
Surveillance médicale
Hémophilie
Prévention des blessures
Éducation des patients
Hémostatiques
Traitements
5
Acide tranexamique
Vitamine K
Administration de médicaments
Hémostatiques
Saignement post-opératoire
Hémostatiques
Agents hémostatiques
Chirurgie
Effets secondaires
Hémostatiques
Complications
5
Réaction allergique
Antihistaminiques
Prévention des complications
Suivi médical
Signes d'alerte
Complications
Facteurs de risque
5
Facteurs de risque
Anticoagulants
Âge
Troubles de la coagulation
Médicaments
Anticoagulants
Maladies hépatiques
Coagulation
Comportements à risque
Alcool
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hémostatiques : Questions médicales les plus fréquentes",
"headline": "Hémostatiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hémostatiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-08",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hémostatiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coagulants",
"url": "https://questionsmedicales.fr/mesh/D003029",
"about": {
"@type": "MedicalCondition",
"name": "Coagulants",
"code": {
"@type": "MedicalCode",
"code": "D003029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agents d'inversion des anticoagulants",
"alternateName": "Anticoagulant Reversal Agents",
"url": "https://questionsmedicales.fr/mesh/D000089964",
"about": {
"@type": "MedicalCondition",
"name": "Agents d'inversion des anticoagulants",
"code": {
"@type": "MedicalCode",
"code": "D000089964",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270.463.046"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antifibrinolytiques",
"alternateName": "Antifibrinolytic Agents",
"url": "https://questionsmedicales.fr/mesh/D000933",
"about": {
"@type": "MedicalCondition",
"name": "Antifibrinolytiques",
"code": {
"@type": "MedicalCode",
"code": "D000933",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270.463.091"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hémostatiques",
"alternateName": "Hemostatics",
"code": {
"@type": "MedicalCode",
"code": "D006490",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Patricia Davenport",
"url": "https://questionsmedicales.fr/author/Patricia%20Davenport",
"affiliation": {
"@type": "Organization",
"name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States."
}
},
{
"@type": "Person",
"name": "Martha Sola-Visner",
"url": "https://questionsmedicales.fr/author/Martha%20Sola-Visner",
"affiliation": {
"@type": "Organization",
"name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States."
}
},
{
"@type": "Person",
"name": "Reihaneh Haghniaz",
"url": "https://questionsmedicales.fr/author/Reihaneh%20Haghniaz",
"affiliation": {
"@type": "Organization",
"name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States."
}
},
{
"@type": "Person",
"name": "Ali Khademhosseini",
"url": "https://questionsmedicales.fr/author/Ali%20Khademhosseini",
"affiliation": {
"@type": "Organization",
"name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States."
}
},
{
"@type": "Person",
"name": "A B Zemlyanoy",
"url": "https://questionsmedicales.fr/author/A%20B%20Zemlyanoy",
"affiliation": {
"@type": "Organization",
"name": "Pirogov National Medical and Surgical Center of Ministry of Health of Russia, Moscow, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "(Non-)disclosure of lifetime sexual violence in maternity care: Disclosure rate, associated characteristics and reasons for non-disclosure.",
"datePublished": "2023-10-04",
"url": "https://questionsmedicales.fr/article/37792790",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0285776"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disclosure of Sexual Victimization: Effects of Invalidation and Shame on Re-Disclosure.",
"datePublished": "2023-02-20",
"url": "https://questionsmedicales.fr/article/36803032",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/08862605231155122"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development and Validation of the Disclosure Expectancy Scale.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36321556",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10731911221128947"
}
},
{
"@type": "ScholarlyArticle",
"name": "Informed consent, price transparency, and disclosure.",
"datePublished": "2023-07-28",
"url": "https://questionsmedicales.fr/article/37506217",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bioe.13206"
}
},
{
"@type": "ScholarlyArticle",
"name": "Influence of agent's self-disclosure on human empathy.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37163467",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0283955"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents hématologiques",
"item": "https://questionsmedicales.fr/mesh/D006401"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coagulants",
"item": "https://questionsmedicales.fr/mesh/D003029"
},
{
"@type": "ListItem",
"position": 7,
"name": "Hémostatiques",
"item": "https://questionsmedicales.fr/mesh/D006490"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hémostatiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hémostatiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hémostatiques",
"description": "Comment diagnostiquer un trouble de la coagulation ?\nQuels signes indiquent un besoin d'hémostatiques ?\nQuels tests pour évaluer l'efficacité des hémostatiques ?\nComment évaluer un saignement post-opératoire ?\nQuels antécédents médicaux sont pertinents ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Disclosure#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hémostatiques",
"description": "Quels sont les symptômes d'un saignement excessif ?\nComment reconnaître une hémorragie interne ?\nQuels signes d'alerte pour les troubles de la coagulation ?\nQuels symptômes d'une réaction aux hémostatiques ?\nComment identifier une thrombose ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Disclosure#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hémostatiques",
"description": "Comment prévenir les saignements chez les patients à risque ?\nQuels conseils pour éviter les saignements ?\nComment surveiller les patients sous anticoagulants ?\nQuelles mesures pour les patients hémophiles ?\nComment éduquer les patients sur les hémostatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Disclosure#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hémostatiques",
"description": "Quels sont les principaux hémostatiques utilisés ?\nComment administrer des hémostatiques ?\nQuels traitements pour les saignements post-opératoires ?\nQuand utiliser des agents hémostatiques locaux ?\nQuels sont les effets secondaires des hémostatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Disclosure#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hémostatiques",
"description": "Quelles complications peuvent survenir avec les hémostatiques ?\nComment gérer une réaction allergique aux hémostatiques ?\nQuels risques de thrombose avec des hémostatiques ?\nComment prévenir les complications liées aux hémostatiques ?\nQuels signes d'alerte pour des complications ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Disclosure#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hémostatiques",
"description": "Quels facteurs augmentent le risque de saignement ?\nComment l'âge influence-t-il le risque de saignement ?\nQuels médicaments augmentent le risque de saignement ?\nComment les maladies hépatiques affectent-elles la coagulation ?\nQuels comportements augmentent le risque de saignement ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Disclosure#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble de la coagulation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins comme le temps de prothrombine et le temps de saignement sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un besoin d'hémostatiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements excessifs, des ecchymoses fréquentes ou des saignements prolongés peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité des hémostatiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests comme le temps de thrombine et le temps de céphaline activé."
}
},
{
"@type": "Question",
"name": "Comment évaluer un saignement post-opératoire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On examine la quantité de sang perdu et la durée du saignement après la chirurgie."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont pertinents ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles de la coagulation ou d'utilisation d'anticoagulants sont importants."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un saignement excessif ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des ecchymoses, des saignements de nez fréquents et des gencives qui saignent."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie interne ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, des vertiges ou une pâleur peuvent indiquer une hémorragie interne."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour les troubles de la coagulation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements prolongés après une coupure ou des saignements inhabituels sont des signes d'alerte."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une réaction aux hémostatiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou des difficultés respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment identifier une thrombose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement, une douleur ou une rougeur dans une jambe peuvent indiquer une thrombose."
}
},
{
"@type": "Question",
"name": "Comment prévenir les saignements chez les patients à risque ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut prescrire des hémostatiques préventifs avant des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Quels conseils pour éviter les saignements ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les anticoagulants non prescrits et maintenir une bonne hygiène dentaire."
}
},
{
"@type": "Question",
"name": "Comment surveiller les patients sous anticoagulants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des contrôles réguliers de la coagulation sanguine sont nécessaires pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour les patients hémophiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients hémophiles doivent éviter les sports de contact et suivre un traitement préventif."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les hémostatiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur l'utilisation correcte, les effets secondaires et l'importance du suivi médical."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux hémostatiques utilisés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les hémostatiques courants incluent l'acide tranexamique et la vitamine K."
}
},
{
"@type": "Question",
"name": "Comment administrer des hémostatiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par voie orale, intraveineuse ou topique selon le type."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les saignements post-opératoires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut utiliser des compresses, des sutures ou des hémostatiques pour contrôler le saignement."
}
},
{
"@type": "Question",
"name": "Quand utiliser des agents hémostatiques locaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés lors de chirurgies pour contrôler les saignements au site opératoire."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des hémostatiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des réactions allergiques, des nausées ou des thromboses."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les hémostatiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des thromboses, des réactions allergiques ou des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique aux hémostatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut arrêter le traitement et administrer des antihistaminiques ou des corticostéroïdes si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels risques de thrombose avec des hémostatiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation excessive d'hémostatiques peut augmenter le risque de thrombose veineuse profonde."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux hémostatiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un ajustement des doses peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des essoufflements ou des gonflements doivent alerter immédiatement."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de saignement ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'utilisation d'anticoagulants et certaines maladies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque de saignement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées ont un risque accru de troubles de la coagulation et de saignements."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque de saignement ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants, les anti-inflammatoires non stéroïdiens et certains antibiotiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment les maladies hépatiques affectent-elles la coagulation ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies hépatiques peuvent altérer la production de facteurs de coagulation, augmentant le risque de saignement."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de saignement ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "La consommation excessive d'alcool et le tabagisme peuvent augmenter le risque de saignement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Pirogov National Medical and Surgical Center of Ministry of Health of Russia, Moscow, Russia.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan. nnhk110184@kpe.biglobe.ne.jp.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
96702State Key Laboratory of NBC Protection for Civilian, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
96702State Key Laboratory of NBC Protection for Civilian, Beijing, PR China.
Publications dans "Hémostatiques" :
In maternity care, disclosure of a past sexual violence (SV) experience can be helpful to clients to discuss specific intimate care needs. Little evidence is available about the disclosure rates of SV...
The aim of this study was to examine (1) the disclosure rate of SV in maternity care, (2) characteristics associated with disclosure of SV and (3) reasons for non-disclosure....
We conducted a descriptive mixed method study in the Netherlands. Data was collected through a cross-sectional online questionnaire with both multiple choice and open-ended items. We performed binary ...
In our sample of 1,120 respondents who reported SV, 51.9% had disclosed this to a maternity care provider. Respondents were less likely to disclose when they received obstetrician-led care for high-ri...
The high level of SV disclosure is likely due to the Dutch universal screening policy. However, some respondents did not disclose because of unsafe care conditions such as the presence of a third pers...
Research on disclosure of sexual victimization has consistently demonstrated that the act of disclosure and the disclosure recipient have a synergistic effect in facilitating either positive or negati...
Although the disclosure of traumatic experiences is believed to influence trajectories of post-trauma recovery, less is known about individual differences that affect survivors' motivation to share. T...
In the American medical system, patients do not know the final price of treatment until long after the treatment is given, at which point it is too late to say "no." I argue that without price disclos...
As AI technologies progress, social acceptance of AI agents, including intelligent virtual agents and robots, is becoming even more important for more applications of AI in human society. One way to i...
Sexual violence (SV) has been a prevalent issue on college campuses for decades. Researchers, universities, and legislators have tried to understand and prevent it. Despite these efforts, 25% of femal...
The current paper aims to compile and summarize the extant literature on undergraduate student disclosures of sexual violence. The objective is to provide a comprehensive review of the research....
A literature search was performed using the terms sexual violence, NSE, undergraduate students, informal and formal reporting, and disclosure....
Disclosure patterns and outcomes for survivors vary widely based on individual factors including type of disclosure source (ie, informal or formal reporting), disclosure recipient response, previous h...
The individualized response and decision to report SV has made prevention and the creation of effective resources difficult. As there are so many individual factors to consider when evaluating how or ...
Adolescents comprise a vulnerable population that is exposed to crime and also may be reluctant to disclose full details of their experiences. Little research has addressed effective ways of increasin...
The use of formal privacy to protect the confidentiality of responses in the 2020 Decennial Census of Population and Housing has triggered renewed interest and debate over how to measure the disclosur...
Healthcare regulators and patients are increasingly interested in financial transparency between physicians and the industry because of concerns of bias....
Disclosures for every first and last author with a medical degree from the United States associated with a poster or podium presentation at the American Academy of Orthopaedic Surgeons (AAOS) 2019 Ann...
In total, 2,503 AAOS presenters were identified, and 1,380 authors met the inclusion criteria. Using AAOS disclosures as the standard comparator, 482 authors (35%) had an inconsistency in any category...
Although the inconsistency rate for each category has improved over the years, the overall inconsistency rate between physician-reported disclosures at a recent AAOS Annual Meeting and industry-report...
Cystic fibrosis (CF), a genetic disease and chronic illness, affects multiple organ systems and requires exceptional medical care and treatment. Few studies have assessed the diagnosis disclosure proc...